Prostate Cancer International is a
non-profit for 2012 as rated by Great NonProfits
Here in the USA, the two main organizations representing the primary care community ( the American College of Physicians [ACP] and the American Academy of Family Physicians [AAFP]) have taken no specific position on early detection and screening for prostate cancer since the ACP issued a now “inactive” guideline in 1997. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: early detection, guideline, policy, screening | 1 Comment »
At the beginning of November, we commented on a re-analysis of the PLCO data by Crawford et al. — a re-analysis that focused on the impact of co-morbidities on treatment and outcomes over time. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Co-morbidity, early detection, localized, low risk, Management, screening | Leave a Comment »
State-based men’s health and prostate cancer initiatives across America are beginning to be seriously affected by budget crises now being addressed by legislatures across the country. … READ MORE …
Filed under: Diagnosis, Prevention, Risk | Tagged: early detection, Illinois | Leave a Comment »
Two opinion-leaders behind the development and execution of the European Randomized Study of Screening for Prostate Cancer (ERSPC) have asked whether data from that trial and from the Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) screening trial have “resolved the controversy” about the need for mass, population-based “screening” for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: early detection, screening | Leave a Comment »
In 2008, Vickers et al. initially proposed that a panel of four kallikrein markers, together with patient age, could potentially reduce the need for unnecessary biopsies in previously untested men with an elevated PSA level and a theoretical risk for prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: early detection, kallikrein, PSA | 2 Comments »
A critical session at the GU cancer meeting this morning was designed to address the pros and cons of screening patients for prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Prevention, Risk | Tagged: early detection, Prevention, screening | 5 Comments »
The following media release, referring to the new screening and early detection guidelines issued by the American Cancer Society, was distributed earlier today by Prostate Cancer International and other members of America’s Prostate Cancer Organizations: … READ MORE …
Filed under: Diagnosis, Risk | Tagged: early detection, guidelines, screening | 3 Comments »
The Canary Foundation and Stanford University Medical Center have today announced their joint commitment of $20 million to create the Canary Center at Stanford for Cancer Early Detection, a world-class research center dedicated to improving cancer early detection. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: Canary Foundation, early detection, Stanford | Leave a Comment »
A new analysis by Scales et al., to be published in Cancer, finds that one in five men aged 40 and above has had a PSA test within the previous year and that young black men are more likely than young white men to have undergone the test. … READ MORE …
Filed under: Diagnosis, Prevention | Tagged: cancer, early detection, prostate, PSA, screening | Leave a Comment »
In 1996, the U.S. Preventive Services Task Force (U.S. PSTF) first issued a report stating that the benefits of screening for prostate cancer were far outweighed by the risks. This report was updated in 2002.
As of today, Tuesday August 5, 2008, the U.S. PSTF has issued another updated version of their guidelines on this subject … and they are still of the opinion that the potential risks of screening far outweigh the potential benefits. … MORE …
Filed under: Diagnosis, Tips | Tagged: adverse effects, benefit, Diagnosis, early detection, risk, screening | 11 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site